(Cys18)-Atrial Natriuretic Factor (4-18) amide (mouse, rabbit, rat) features a cysteine modification at position 18 to enable cross-linking and receptor stabilization. The amide group at the C-terminus increases peptide stability. This analog is commonly used in studies examining the regulation of blood pressure and fluid balance through the atrial natriuretic peptide system.
CAT No: A17003
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More